Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PRAM1 anticorps (AA 551-650) (Biotin)

Cet anticorps anti-PRAM1 est un anticorps Lapin Polyclonal détectant PRAM1 dans ELISA, IHC (p) et IHC (fro). Adapté pour Humain.
N° du produit ABIN1700382

Aperçu rapide pour PRAM1 anticorps (AA 551-650) (Biotin) (ABIN1700382)

Antigène

Voir toutes PRAM1 Anticorps
PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))

Reactivité

  • 20
  • 1
Humain

Hôte

  • 18
  • 1
  • 1
Lapin

Clonalité

  • 20
Polyclonal

Conjugué

  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PRAM1 est conjugé à/à la Biotin

Application

  • 13
  • 13
  • 5
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Épitope

    • 14
    • 2
    • 1
    • 1
    • 1
    AA 551-650

     Réactivité croisée

    Humain

    Homologie

    Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human PRAM1

    Isotype

    IgG
  • Indications d'application

    IHC-P 1:200-400
    IHC-F 1:100-500

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C for 12 months.

    Date de péremption

    12 months
  • Antigène

    PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))

    Autre désignation

    PRAM1

    Sujet

    Synonyms: PML RAR, PML RARA regulated adaptor molecule 1, PML RARA target gene encoding an Adaptor Molecule 1, PML-RARA-regulated adapter molecule 1, PRAM 1, PRAM, PRAM-1, PRAM_HUMAN, PRAM1.

    Background: Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia cells. The retinoic acid-induced gene, PRAM-1 (PML-RAR-a target gene encoding an adaptor molecule 1) encodes an adaptor protein which is expressed and modulated during normal human myelopoiesis. PRAM-1 expression is hindered by expression of PML-RAR-a. The 718 amino acid PRAM-1 protein contains eight N-terminal proline-rich repeats and several proline residues that are clustered as type I or type II SH3 recognition motifs. PRAM-1 demonstrates expression in hematopoietic tissues and lung.

    Pathways

    Regulation of Leukocyte Mediated Immunity
Vous êtes ici:
Chat with us!